COMMUNIQUÉS West-GlobeNewswire

Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results

14/02/2025 - 22:30

CARLSBAD, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]

Author Andrew Leland Receives 2025 Helen Keller Achievement Award

13/02/2025 - 15:44

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The American Foundation for the Blind (AFB) is pleased to announce author Andrew Leland will be among those to receive the prestigious Helen Keller Achievement Award, which [...]

USOSM Expands Best-in-Class Network of Premier Oral and Maxillofacial Surgeons

13/02/2025 - 15:45

Secures New Partner Practices on East and West Coasts IRVING, Texas, Feb. 13, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) is pleased to announce new partnerships with three premier oral and [...]

Medicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones

13/02/2025 - 16:28

- Disease control rate (DCR) of 78% (7 of 9) in combination escalation arm of MDNA11 with Merck’s (known as MSD outside of Canada and the US) KEYTRUDA ® (pembrolizumab) in ongoing Phase 1/2 ABILITY-1 trial including one [...]

LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

13/02/2025 - 16:35

PASADENA, CALIF., Feb. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced the closing of its [...]

Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results

13/02/2025 - 17:00

Press Release – No. 3 / 2025 Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results Copenhagen, Denmark, February 13, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: [...]

Nutrify Today C-Suite Sumflex 2025 Shaping the Future of Nutraceuticals

13/02/2025 - 17:20

MUMBAI, India, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Nutrify Today will host C-Suite Sumflex 2025 on May 8-9, at the Trident and Oberoi Hotels in Mumbai, bringing together industry leaders, investors, and policymakers to [...]

Ultimovacs ASA: Cancellation of subsequent repair offering

13/02/2025 - 17:30

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. [...]

Merus fera une présentation lors du Citi's 2025 Virtual Oncology Leadership Summit

13/02/2025 - 17:56

UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 13 févr. 2025 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq : MRUS), une société d’oncologie au stade clinique développant des anticorps de pleine longueur multispécifiques et [...]

EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2025

13/02/2025 - 18:00

Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025

13/02/2025 - 18:00

Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

Over 120 Epilepsy Organizations Applaud the Introduction of the National Plan for Epilepsy Act in Congress

13/02/2025 - 18:45

The National Plan aims to support the 3.4 million people living with epilepsy in the United States through a unified approach, calling for bipartisan support. BOWIE, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Epilepsy [...]

The Shift Towards Proactive Health: Biologic Pharmamedical Stands Firm Amidst Tariffs and Big Pharma Shakeup

13/02/2025 - 18:52

RICHMOND, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- As the healthcare and supplement industries experience seismic shifts—driven by new U.S. tariffs, growing scrutiny on Big Pharma, and rising pharmaceutical [...]

Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain

13/02/2025 - 20:09

Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris, le 13 février 2025 . Sanofi annonce avoir déposé son Document d’Enregistrement Universel [...]

Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report

13/02/2025 - 20:09

Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 13, 2025 . Sanofi announces today the filing of its Form 20-F with the U.S. [...]

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report

13/02/2025 - 21:14

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period and [...]

Cytokinetics to Announce Fourth Quarter Results on February 27, 2025

13/02/2025 - 22:00

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter results on February 27, 2025 at 4:00 PM Eastern Time [...]

Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

13/02/2025 - 22:01

2024 Total Revenue of $560 million, exceeding guidance Crysvita® revenue of $410 million and Dojolvi® revenue of $88 million 2025 Financial Guidance: Total Revenue between $640 million to $670 million, Crysvita revenue [...]

AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

13/02/2025 - 22:01

VALENCIA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for [...]